Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06678295 · ClinicalTrials.gov registry record · NA

Individual Factors of CBT Underlying Success

A NA study of Social Anxiety Disorder and Body Dysmorphic Disorder, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT06678295 is a NA study of Social Anxiety Disorder and Body Dysmorphic Disorder that is actively recruiting participants, run by University of Washington. The registered enrollment target is 160 participants, roughly in line with the 155-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06678295, a NA study of Social Anxiety Disorder and Body Dysmorphic Disorder, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand why some individuals respond fully to cognitive behavioral therapy and others do not, based on multiple sources of data such as neural, neurocognitive, clinical, and self-report data.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2024-10-15
Est. Completion 2028-09-30
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT06678295

The ClinicalTrials.gov registry entry for NCT06678295 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 155-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Social Anxiety Disorder appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.

NCT06678295 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT06678295 about?

NCT06678295 is a clinical study titled "Individual Factors of CBT Underlying Success". The purpose of this study is to understand why some individuals respond fully to cognitive behavioral therapy and others do not, based on multiple sources of data such as neural, neurocognitive, clinical, and self-report data.

What is the current status of trial NCT06678295?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2024-10-15. Estimated completion is 2028-09-30.

What conditions does trial NCT06678295 study?

This clinical trial studies the following conditions: Social Anxiety Disorder, Body Dysmorphic Disorder.

What interventions are being tested in trial NCT06678295?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06678295?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06678295 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Social Anxiety Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.